
“Unlocking Potential: The Exciting Potential of Viking Therapeutics’ Oral VK2735 Phase 2 Readout”
Oral VK2735: Revolutionizing the Obesity Market The Rise of Oral GLP-1 Therapies Oral VK2735 is poised to disrupt the obesity market with its innovative approach to treating weight loss. As a best-in-class oral GLP-1 therapy, VK2735 offers a unique solution for patients looking to manage their weight without the hassle of injections. The Phase 2…